Sharabi, Kfir
Tavares, Clint D. J.
Puigserver, Pere
Article History
First Online: 7 September 2019
Compliance with Ethical Standards
:
: Kfir Sharabi and Pere Puigserver have a pending patent to DFCI on selective inhibition of gluconeogenic activity.Clint D. J. Tavares declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.